Barrington Research Increases Henry Schein (HSIC) Price Target to $96.00

Share on StockTwits

Henry Schein (NASDAQ:HSIC) had its price objective raised by stock analysts at Barrington Research from $92.00 to $96.00 in a report released on Thursday, MarketBeat reports. The brokerage presently has an “outperform” rating on the stock. Barrington Research’s price target suggests a potential upside of 12.37% from the company’s previous close.

The analysts wrote, “We are currently modeling $4.10. It is important to note that management’s adjusted EPS guidance does not include any impact from the upcoming animal health spin-off and merger, which is expected to occur around year end. In addition, the guidance does not factor in any future M&A activity.””

Several other analysts also recently issued reports on HSIC. BidaskClub downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Friday, July 13th. Zacks Investment Research downgraded shares of Henry Schein from a “buy” rating to a “hold” rating in a research report on Saturday, July 14th. Stifel Nicolaus increased their price objective on shares of Henry Schein from $76.00 to $81.00 and gave the company a “hold” rating in a research report on Tuesday, August 7th. Robert W. Baird increased their price objective on shares of Henry Schein from $83.00 to $90.00 and gave the company an “outperform” rating in a research report on Tuesday, August 7th. Finally, Craig Hallum increased their price objective on shares of Henry Schein from $83.00 to $96.00 and gave the company a “buy” rating in a research report on Tuesday, August 7th. Two research analysts have rated the stock with a sell rating, nine have given a hold rating, nine have assigned a buy rating and one has assigned a strong buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $84.41.

NASDAQ HSIC traded down $1.54 during mid-day trading on Thursday, hitting $85.43. The company’s stock had a trading volume of 1,332,016 shares, compared to its average volume of 1,635,205. Henry Schein has a 52-week low of $62.56 and a 52-week high of $90.52. The company has a debt-to-equity ratio of 0.29, a quick ratio of 0.68 and a current ratio of 1.30. The firm has a market capitalization of $13.31 billion, a price-to-earnings ratio of 23.73, a PEG ratio of 2.71 and a beta of 0.87.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings results on Tuesday, November 6th. The company reported $1.03 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.01 by $0.02. Henry Schein had a net margin of 3.00% and a return on equity of 20.40%. The firm had revenue of $3.28 billion for the quarter, compared to analyst estimates of $3.37 billion. During the same quarter last year, the firm posted $0.87 earnings per share. Henry Schein’s revenue for the quarter was up 3.8% compared to the same quarter last year. Sell-side analysts forecast that Henry Schein will post 4.12 EPS for the current fiscal year.

Several hedge funds have recently added to or reduced their stakes in HSIC. LPL Financial LLC grew its position in shares of Henry Schein by 19.0% during the first quarter. LPL Financial LLC now owns 7,592 shares of the company’s stock worth $510,000 after buying an additional 1,213 shares in the last quarter. Millennium Management LLC grew its position in shares of Henry Schein by 60.6% during the first quarter. Millennium Management LLC now owns 33,082 shares of the company’s stock worth $2,223,000 after buying an additional 12,482 shares in the last quarter. Allianz Asset Management GmbH grew its position in shares of Henry Schein by 14.3% during the first quarter. Allianz Asset Management GmbH now owns 584,528 shares of the company’s stock worth $39,286,000 after buying an additional 73,176 shares in the last quarter. DnB Asset Management AS grew its position in shares of Henry Schein by 8.3% during the second quarter. DnB Asset Management AS now owns 28,606 shares of the company’s stock worth $2,078,000 after buying an additional 2,200 shares in the last quarter. Finally, IFM Investors Pty Ltd grew its position in shares of Henry Schein by 40.6% during the second quarter. IFM Investors Pty Ltd now owns 7,191 shares of the company’s stock worth $522,000 after buying an additional 2,076 shares in the last quarter.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

Featured Story: Penny Stocks, What You Need To Know

Analyst Recommendations for Henry Schein (NASDAQ:HSIC)

Receive News & Ratings for Henry Schein Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Henry Schein and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply